Wenjuan Ma

2.5k citations
53 papers · 1.9k indexed · 2 hit papers · h-index 26

Wenjuan Ma

51 papers receiving 1.8k citations

Hit Papers

A DNA tetrahedron-based ferroptosis-suppressing nanoparti...1052023202620242025255075100

Peers

Wenjuan Ma
Comparison fields: 5 of 116
  • Molecular Biology 1.0k
  • Biomaterials 182
  • Cancer Research 200
  • Filtration and Separation 22
  • Biomedical Engineering 454
Replace Meng Yang with:
Meng Yang China
Xiaoling Xu China
Andrea Heinz Denmark
Weiliang Xia China
Guillaume Bastiat France
Jinhao Zhang China
Aeri Kim South Korea
Patrizia Cancemi Italy
Xuxia Wang China
Wenjuan Ma relative to Meng Yang China Meng Yang's profile →
Citations per field
00.5×1.5×2.1×
Meng Yang · 1×
Citations per year

Countries citing papers authored by Wenjuan Ma

Since Specialization
Citations

This map shows the geographic impact of Wenjuan Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenjuan Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenjuan Ma more than expected).

Fields of papers citing papers by Wenjuan Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenjuan Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenjuan Ma. The network helps show where Wenjuan Ma may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Wenjuan Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Wenjuan Ma Line = papers co-authored together Wenjuan Ma links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 202428
2 20241
3 202321
4 20232
5 202258
6 20223
7 20224
8 202014
9 2019177
10 201926
11 201910
12 201915
13 201812
14 201870
15 20170
16 201765
17 20171
18 2013251
19
Optimization of Decaisnea Insignis seed oil extraction process and analysis of fatty acid
20122
20
Research on Real-Time Collision Detection Based on Hybrid Hierarchical Bounding Volume
20085

About Wenjuan Ma

Wenjuan Ma is a scholar working on Cancer Research, Aging and Filtration and Separation, having authored 53 papers that have together received 1.9k indexed citations. Recurring topics across this work include Advanced biosensing and bioanalysis techniques (15 papers), RNA Interference and Gene Delivery (13 papers), MicroRNA in disease regulation (6 papers), DNA and Nucleic Acid Chemistry (5 papers), Nanoplatforms for cancer theranostics (5 papers), Angiogenesis and VEGF in Cancer (3 papers), Acute Myeloid Leukemia Research (3 papers) and Chronic Myeloid Leukemia Treatments (3 papers). The work is most often cited by research in Molecular Biology (1.0k citations), Biomaterials (182 citations) and Cancer Research (200 citations). Wenjuan Ma has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Yunfeng Lin, Xiaoru Shao, Xueping Xie, Weitong Cui, Yuxi Zhan, Chenchen Mao, Yuxin Zhang, Qianshun Li, Xiuyan Zhang and Yun Zhao. Their work appears in journals such as Advanced Materials, Nano Letters and The EMBO Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026